Genetic thrombophilia and cerebral venous thrombosis;Trombofilia genética y trombosis de senos venosos cerebrales

Medicina Clinica

Volumn 128, Issue 17, 2007, Pages 655-656

  Romero, Alberto ^a   Marco, Pascual ^a   Verdú, José ^a   Sánchez, Sara ^a   Castaño, Vanesa ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Cerebral venous thrombosis; Factor V Leiden; MTHR; PT 20210A; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HETEROZYGOTE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA;

EID: 34347223974     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13102055     Document Type: Article

References (8)

1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352:1791-8.
2. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338:1793-7.
3. Ludemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case-control study of 55 patients. Stroke. 1998;29:2507-10.
4. Millier CE, Collins PW, Bowen DJ, Bowley S, Wiles CM. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM. 1998;91:677-80.
5. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107:2766-73.
6. Rodrigues CA, Rocha LKA, Morelli VM, Franco RF, Lourenço DM. Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. J Thromb Haemost. 2004;2:1211-2.
7. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210A transition is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:1765-9.
8. García-Hernández MC, Romero A, Marco P, Verdú J, Lucas J. Prevalencia de los marcadores genéticos (factor V Leiden, protrombina 20210A y forma homocigota de la metilen-tetrahidro-folato-reductasa (ho-MTHFR) en el área de salud 18 de la Comunidad Valenciana. Rev Clin Esp. En prensa 2007.